Log inSign up
Jonathan G. Stine, MD MSc, FACP
5,727 posts
Image
user avatar
Jonathan G. Stine, MD MSc, FACP
@JonathanStineMD
Global Clinical Program Lead – Late CVRM @AstraZeneca | #MASH researcher | Clinical Professor of Medicine @Penn_State | #exercise #garden #read | Views my own
Gaithersburg, MD
pure.psu.edu/en/persons/jon…
Joined July 2019
814
Following
2,523
Followers
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Nov 20, 2024
    Join #ZachHenryMD and I for @AmCollegeGastro Virtual Grand Rounds on Thursday December 5th at 12p EST entitled "How to Write an Exercise Prescription to Treat #MASLD for the Busy Clinician" Register here: register.gotowebinar.com/register/79888…
    Image
    29K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Jun 30, 2025
    After 8 yrs in academic medicine, I'm absolutely delighted to announce I’ve joined @AstraZeneca as a Global Clinical Lead. Starting today, I hope to advance innovative therapies for liver & metabolic diseases alongside an incredible team. Onward to this new chapter! #MASLD #MASH
    16K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Jun 20, 2022
    1/2-Excited that NASHFit study featured on this month's @HEP_Journal cover! Benefits of #exercise in #NASH w/o wt loss: 1⃣ Clotting risk (PAI-1) ⬇️ 2⃣ Liver fat (PDFF) ⬇️ 3⃣ Fitness (VO2peak) ⬆️ 4⃣ Body composition, glucose metabolism improved 6⃣ QOL⬆️ pubmed.ncbi.nlm.nih.gov/34890063/
    Image
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Dec 26, 2024
    🔥 🆙 to publish this work with @HD3vedi and team regarding the importance of #exercise across all types and stages of steatotic liver disease! Check it out here:
    Image
    onlinelibrary.wiley.com
    The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
    Background The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), parallels the rise in sedentar...
    161K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Dec 10, 2021
    Excited to share NASHFit study results online now in @HEP_Journal. Bottom line- #exercise has many weight-loss independent benefits: 1⃣ clotting risk ⬇️ 2⃣ PDFF ⬇️ 3⃣ VO2peak ⬆️ 4⃣ Body composition change 5⃣ Better glucose metabolism 6⃣ Improved HRQOL aasldpubs.onlinelibrary.wiley.com/doi/10.1002/he…
    Image
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Nov 29, 2023
    🏋️‍♂️ Exciting findings from the NASHFit trial! Exercise even w/o wt loss improves liver fibroinflam in #MASLD: 53% ALT >=17 IU/L, correlated w/>=30% MRI-PDFF rel ⬇️, ⬇️CK-18 💪#Exercise is a game-changer in fight against liver disease! 🚴‍♀️🍏#LiverHealth onlinelibrary.wiley.com/doi/10.1111/li…
    Image
    17K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Jan 31, 2025
    #MASLD Health Tip of the Day: Enjoy your coffee! Drinking 3 cups of black coffee daily can reduce liver inflammation and support liver health, and has been linked to lower fibrosis A little cream or sugar is okay, but black coffee offers the most benefit. ☕ #LiverHealth
    Image
    9.3K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Aug 4, 2022
    Time to scratch off one more item on the career bucket list ✅ @HEP_Journal cover! Huge thanks to entire team including @DrJazFaust @GIStern3 @fitaftercancer @sciamanna @klkrok @PennStHershey @PennStGastroHep and more!
    user avatar
    Kofi Clarke MD
    @KofiClarkeMD
    Aug 3, 2022
    Very proud of our own @JonathanStineMD !!👏
    Image
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    May 6, 2023
    Alright @DDWMeeting #DDW2023 twitter- who wore it better?
    Image
    8.6K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    May 9, 2025
    Over the 🌑 to find out today that I have been promoted to Full Professor! So grateful for every mentor, collaborator, trainee, friend and especially my family who have helped me along the way. I am so excited to keep pushing forward in research, clinical care, and education.
    6.1K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    May 1, 2023
    It's here! 30 consensus, evidence-based statements about Physical Activity and #NAFLD from @ACSM roundtable out today in @MSSEonline! journals.lww.com/acsm-msse/Abst… @fitaftercancer @DrMTLong @KathleenCoreyMD @drbobsallis @AlinaAllenMD @conroylab @djrcuthbertson @CJAPugh
    Image
    15K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Sep 6, 2023
    Lifestyle interventions in nonalcoholic fatty liver disease | Nature Reviews Gastroenterology & Hepatology
    Content cover image
    Lifestyle interventions in nonalcoholic fatty liver disease
    From nature.com
    5.5K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Feb 15, 2023
    Honored and excited to lead @PennStHershey Fatty Liver Disease Program and bring multidisciplinary #NAFLD care and clinical trials to our patients in central PA! pennstatehealthnews.org/topics/penn-st… @KofiClarkeMD @PennStGastroHep @DrJazFaust @klkrok @EStonesiferMD
    Dr. Jonathan Stine, center, points to a CT scan image as he looks at two people in the Fatty Liver Disease Program. He is wearing a mask and a white coat.
    Penn State Health opens new nonalcoholic Fatty Liver Disease Program
    From pennstatehealthnews.org
    3.4K
  • user avatar
    Jonathan G. Stine, MD MSc, FACP
    @JonathanStineMD
    Dec 2, 2024
    Resistance training isn’t just for strength—it’s a powerhouse for #liver health too! 💪 SR + MA shows significant reductions in liver fat, liver enzymes, IR in #MASLD with RT (6 studies, 232 adults) 😲😲Adherence >90%! 🏋️‍♀️ #ExerciseIsMedicine pubmed.ncbi.nlm.nih.gov/39589803/
    Image
    7K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement